To investigate whether FIH can regulate myeloid Arg1 expression in response to signals secreted by tumor cells, we treated FIH+/+ and FIHΔ1-2/Δ1-2 BMDMs with media that were conditioned by B16 or LLC cell culture supernatants (tumor cell-conditioned medium, TCM). This evidence concerns the gene ARG1 and neoplasm.